Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATX101 in Adults Undergoing Total Knee Arthroplasty
NCT06799845Phase 2Completed
- Sponsor
- Allay Therapeutics
- Start
- Feb 2025
- Primary completion
- Oct 2025
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ATX101 in postoperative pain, sponsored by Allay Therapeutics. Started Feb 2025; status: completed.
02
Drugs
ATX101
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06799845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06799845.